-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Benign prostatic hyperplasia (BPE) is one of the most common diseases in older men, and its incidence increases almost linearly with age.
Quality of Life
Thulium laser excision of the prostate (ThuLEP) is an established regimen for benign prostatic hyperplasia (BPE), but long-term efficacy has not been reported
Thulium laser excision of the prostate (ThuLEP) is an established regimen for benign prostatic hyperplasia (BPE), but long-term efficacy has not been reported Thulium laser excision of the prostate (ThuLEP) is an established regimen for benign prostatic hyperplasia (BPE), but long-term efficacy has not been reported.
Durability of ThuLEP efficacy was demonstrated by investigating long-term efficacy and morbidity
The study included all patients treated with ThuLEP at a tertiary referral center in Germany between 2009 and 2021, who were retrospectively followed to investigate whether prostate adenoma persisted, re-grown (ReIP), or had long-term complications.
A total of 1,097 patients in the study received ThuLEP
Research design
In conclusion, the study investigated the long-term outcomes of thulium laser ablation of benign prostatic hyperplasia (BPE)
Univariate and Multivariate Cox Proportional Hazard Models Analysis of Predictors of Reintervention
Univariate and Multivariate Cox Proportional Hazard Models Analysis of Predictors of ReinterventionTaken together, ThuLEP is a durable, effective and safe procedure with a low reintervention rate at 12 years
ThuLEP is a durable, effective and safe procedure with low reintervention rates at 12 years ThuLEP is a durable, effective and safe procedure with low reintervention rates at 12 years
Original source:
Original source:Britta Grüne, Fabian Siegel, Frank Waldbillig et al.
Long-term Reinterventions after Thulium Laser Enucleation of the Prostate: 12-Year Experience with more than 1000 Patients
leave a message here
